Indoco Remedies Limited (IN:INDOCO)
:INDOCO
Want to see IN:INDOCO full AI Analyst Report?
Total Valuation
Indoco Remedies Limited has a market cap or net worth of ₹19.50B. The enterprise value is ₹29.40B.
Market Cap₹19.50B
Enterprise Value₹29.40B
Share Statistics
Indoco Remedies Limited has 92,303,604 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding92,303,604
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Indoco Remedies Limited’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is 0.69%.
Return on Equity (ROE)-0.11
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)0.69%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee3.08M
Profits Per Employee-164.50K
Employee Count6,000
Asset Turnover0.71
Inventory Turnover2.70
Valuation Ratios
The current PE Ratio of Indoco Remedies Limited is ―. Indoco Remedies Limited’s PEG ratio is -0.61.
PE Ratio―
PS Ratio0.79
PB Ratio1.55
Price to Fair Value1.55
Price to FCF-12.67
Price to Operating Cash Flow10.90
PEG Ratio-0.61
Income Statement
In the last 12 months, Indoco Remedies Limited had revenue of 18.45B and earned -987.00M in profits. Earnings per share was -10.70.
Revenue18.45B
Gross Profit7.51B
Operating Income153.50M
Pretax Income-1.07B
Net Income-987.00M
EBITDA1.42B
Earnings Per Share (EPS)-10.70
Cash Flow
In the last 12 months, operating cash flow was 1.58B and capital expenditures -1.04B, giving a free cash flow of 540.40M billion.
Operating Cash Flow1.58B
Free Cash Flow540.40M
Free Cash Flow per Share5.85
Dividends & Yields
Indoco Remedies Limited pays an annual dividend of ₹0.2, resulting in a dividend yield of 0.08%
Dividend Per Share₹0.2
Dividend Yield0.08%
Payout Ratio-1.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.18
52-Week Price Change-15.89%
50-Day Moving Average204.68
200-Day Moving Average244.58
Relative Strength Index (RSI)47.50
Average Volume (3m)38.33K
Important Dates
Indoco Remedies Limited upcoming earnings date is Jul 28, 2026, TBA (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateJul 28, 2026
Ex-Dividend Date―
Financial Position
Indoco Remedies Limited as a current ratio of 1.13, with Debt / Equity ratio of 116.02%
Current Ratio1.13
Quick Ratio0.75
Debt to Market Cap0.72
Net Debt to EBITDA7.45
Interest Coverage Ratio0.13
Taxes
In the past 12 months, Indoco Remedies Limited has paid -78.10M in taxes.
Income Tax-78.10M
Effective Tax Rate0.07
Enterprise Valuation
Indoco Remedies Limited EV to EBITDA ratio is 17.74, with an EV/FCF ratio of -21.85.
EV to Sales1.36
EV to EBITDA17.74
EV to Free Cash Flow-21.85
EV to Operating Cash Flow77.56
Balance Sheet
Indoco Remedies Limited has ₹231.50M in cash and marketable securities with ₹9.99B in debt, giving a net cash position of -₹9.76B billion.
Cash & Marketable Securities₹231.50M
Total Debt₹9.99B
Net Cash-₹9.76B
Net Cash Per Share-₹105.69
Tangible Book Value Per Share₹82.23
Margins
Gross margin is 54.90%, with operating margin of 0.83%, and net profit margin of -5.35%.
Gross Margin54.90%
Operating Margin0.83%
Pretax Margin-5.77%
Net Profit Margin-5.35%
EBITDA Margin7.68%
EBIT Margin0.83%
Analyst Forecast
The average price target for Indoco Remedies Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.73%
EPS Growth Forecast-31.79%